newsfilter
← Latest News
Business Wire·

Axcella Reports Second Quarter Financial Results and Provides Business Update

Announced Statistically Significant Clinical Improvement in Fatigue in the Phase 2A Long COVID Trial Topline data NASH Trial interim Data Expected in Late Q3 2022 Company to Host Conference Call at 8:30 a.m. ET today Axcella Therape